Stay updated on Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded Melanoma and related topics (MedlinePlus Genetics) to the page’s related topics, and updated the revision indicator from v3.6.5 to v3.6.6. These changes serve metadata/navigation purposes rather than altering the study details.SummaryDifference0.2%

- Check22 days agoChange DetectedThe page now lacks the Melanoma label and related-topic links, indicating a pruning of topic signals and external resource references within the study details.SummaryDifference0.2%

- Check36 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page, signaling a small metadata/format update.SummaryDifference0.1%

- Check51 days agoChange DetectedMelanoma is added as a topic, and MedlinePlus Genetics is listed as a related resource. The page revision was updated from v3.6.3 to v3.6.4.SummaryDifference0.2%

- Check65 days agoChange DetectedThe related topics section was trimmed by removing Melanoma and MedlinePlus Genetics entries. This reduces the external resources shown alongside the study details.SummaryDifference0.2%

- Check73 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a new version of the page. This update does not alter the study content or functionality.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.